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Abstract
The functional catechol-O-methyltransferase (COMT Val108/158Met) polymorphism has been shown to
have an impact on tasks of executive function, memory and attention and recently, tasks with an aﬀective
component. As oestrogen reduces COMT activity, we focused on the interaction between gender and
COMT genotype on brain activations during an aﬀective processing task. We used functional MRI (fMRI)
to record brain activations from 74 healthy subjects who engaged in a facial aﬀect recognition task ;
subjects viewed and identiﬁed fearful compared to neutral faces. There was no main eﬀect of the COMT
polymorphism, gender or genotypergender interaction on task performance. We found a signiﬁcant
eﬀect of gender on brain activations in the left amygdala and right temporal pole, where females
demonstrated increased activations over males. Within these regions, Val/Val carriers showed greater
signal magnitude compared to Met/Met carriers, particularly in females. The COMT Val108/158Met
polymorphism impacts on gender-related patterns of activation in limbic and paralimbic regions but the
functional signiﬁcance of any oestrogen-related COMT inhibition appears modest.
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Introduction
Catechol-O-methyltransferase (COMT) is involved in
the degradation of catecholamine neurotransmitters.
The gene that codes for the COMT enzyme contains
a functional single nucleotide polymorphism at codon
158 with a valine (Val) substitution to methionine
(Met) (Val158Met). The substitution of Val for Met
is responsible for decreased enzymatic activity
(Lotta et al., 1995) with Met homozygotes showing
approximately one third less than Val158 homo-
zygotes (Lachman et al., 1996). COMT provides the
main mechanism for the degradation of released
cortical dopamine (DA) (Gogos et al., 1998 ; Karoum
et al., 1994a, b) and the Val158Met polymorphism
seems to lead to signiﬁcant variations in cognitive
function.
Egan et al. (2001) were the ﬁrst to report an associ-
ation between the low-activity Met allele with fewer
perseverative errors in the Wisconsin Card Sorting
Test (WCST) and a more eﬃcient task-related pattern
of activation in the prefrontal cortex (PFC) in healthy
participants. This lead Egan et al. to suggest that in the
PFC, the COMT Val158 allele contributed to reduced
DA signalling and neuronal signal-to-noise ratio. Since
then, the eﬀect of allelic variation of the COMT gene
on cognitive function in healthy individuals has been
extensively examined; here were report on ﬁndings
pertaining to healthy individuals only from studies
where they were either the main focus of the in-
vestigation or provided a control group for patient
samples. The association between the low-activity Met
allele and enhanced PFC eﬃciency in healthy partici-
pants has been replicated (Malhotra et al., 2002) and
expanded to include the domains of working memory
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(Bertolino et al., 2006a; Mattay et al., 2003) ; encoding
and retrieval (Bertolino et al., 2006b; Schott et al.,
2006) ; and attention (Blasi et al., 2005). However, there
have been studies reporting no eﬀect of the COMT
genotype in healthy individuals (Goldberg et al., 2003;
Joober et al., 2002).
Currently the focus is on the eﬀects of COMT poly-
morphism on emotional processing based on its re-
ported association with personality traits such as the
Met/Met genotype association with increased harm
avoidance (Enoch et al., 2003), neuroticism among fe-
males (Eley et al., 2003) and outward acting aggression
(Rujescu et al., 2003). There is also an association
of COMT genotype with panic disorder (Domschke
et al., 2004 ; Hamilton et al., 2002 ; Woo et al., 2002,
2004) and less so with depression (Massat et al., 2005;
Ohara et al., 1998).
Two recent functional magnetic resonance imaging
(fMRI) studies of healthy adults found an association
between the number of Met alleles and increased ac-
tivation in the amygdala/hippocampus complex in
response to unpleasant pictures (Smolka et al., 2005)
and in the right hippocampus and ventrolateral PFC
when subjects viewed angry and fearful faces com-
pared to geometric shapes (Drabant et al., 2006). This
association between the number of Met alleles and
increased limbic activation has been interpreted as
evidence of reduced emotional resilience conferred by
the Met allele.
COMT activity is signiﬁcantly lower in females
than males (Boudikova et al., 1990 ; Fahndrich et al.,
1980 ; Floderus et al., 1981), a ﬁnding attributed to
the inhibitory eﬀect of oestrogen on COMT gene tran-
scription (Jiang et al., 2003 ; Xie et al., 1999). It is
thought that this sexually dimorphic eﬀect of
COMT Val/Met polymorphism on catecholamine
metabolism may mediate, at least in part, the in-
creased prevalence of anxiety and depression in fe-
males (Kessler et al., 1993, 1994 ; Weissman and
Klerman, 1977). Indeed several studies have found
panic disorder to be associated with the Val158Met
polymorphism only in females (Domschke et al., 2004;
Woo et al., 2004).
However, the behavioural expression of the in-
teraction between gender and COMT appears com-
plex. Studies examining single-sex samples have
not found any eﬀect of COMT Val158Met genotype
on working memory or sustained attention in males
(Smyrnis et al., 2007) or on perseverative errors in fe-
males (Tsai et al., 2003). Enoch et al. (2003) and Stein
et al. (2005) found an eﬀect of Val158Met polymor-
phism on harm avoidance and on the combination of
low extraversion and high neuroticism only in females
whilst Jabbi et al. (2007) found stress responses to
be greater in male compared to female Met homo-
zygotes.
This study focuses speciﬁcally on the interaction
between the COMT Val/Met polymorphism and gen-
der on patterns of brain activation during fMRI in
healthy participants whilst performing a fearful facial
aﬀect recognition task. Fearful faces were chosen
for two reasons. First, most of the evidence for an eﬀect
of the COMT Val/Met polymorphism relate to anxiety
traits or disorders where there is heightened respon-
sivity to threat-related cues (Beck and Clark, 1997;
Mathews, 1998).
Second, males are less accurate and sensitive than
females in labelling facial expressions but there is no
gender diﬀerence in processing fearful expressions
(Montagne et al., 2005) thus reducing potential con-
founders due to performance. Processing of fearful
facial aﬀect engages a widespread neural network
with the most consistently found regions being the
amygdala as well as the orbitofrontal and anterior
cingulate cortices (Murphy et al., 2003 ; Phan et al.,
2002).
Given the evidence for lower COMT activity in fe-
males and the risk of reduced emotional resilience
conferred by the COMT 158Met allele we hypoth-
esized that females homozygotes for the Met allele,
would have the lowest enzyme activity and putatively
higher DA concentrations and would therefore show
ampliﬁed task-induced activations within limbic re-
gions. These predictions are based speciﬁcally on the
eﬀect of the COMT genotype on the limbic system
without fully accounting for the interaction of pre-
frontal and amygdala networks (Bilder et al., 2004).
The eﬀect of the COMT genotype is pronounced
within the PFC with the Met allele being associated
with increased cognitive control. It is therefore poss-
ible that a genotype-associated prefrontal-associated
mechanism can override the eﬀect of the genotype
within the limbic regions.
Materials and methods
Subjects
Seventy-four healthy adults took part in this study
(Table 1). Participants were recruited by advert and
were included if they (a) were aged 18–65 yr, (b) had
no personal lifetime history of mental health prob-
lems, substance use, head injury or medical disorders,
(c) did not take any prescribed medication, (d) were of
self-reported British white ancestry, (e) had no met-
allic objects in their body.
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Assessment
Participants were screened for the absence of any Axis
I or Axis II diagnoses according to DSM-IV criteria
(APA, 1994) following personal interview by trained
psychiatrists using Structured Clinical Interview for
DSM-IV (non-patient version) (First et al., 2002) and
the SCID-II Personality Questionnaire for Axis II di-
agnoses (First et al., 1997).
An estimate of current intellectual function (IQ) was
obtained using a shortened version of the Wechsler
Adult Intelligence Scale – Revised (WAIS-R;Wechsler,
1981). Educational level was scored on a 5-point scale,
where 1 indicated no formal qualiﬁcations and 5 in-
dicated postgraduate-level qualiﬁcations.
The study was approved by the Ethics Committee
of the Institute of Psychiatry and the South London
and Maudsley NHS Trust. Written informed consent
was obtained from all participants.
DNA extraction and genotyping
DNA was obtained from buccal swabs using estab-
lished procedures (Freeman et al., 2003). The COMT
Met/Val (rs4680) genotype was determined by a
TaqMan Drug Metabolizing Genotyping assay (Ap-
plied Biosystems, Assay ID C_25746809_50) using the
manufacturer’s instructions. Endpoint analysis was
performed on an ABI7900 DNA analyser and geno-
types called with the SDS package with a probability
>95%. To improve genotyping reliability suﬃcient
additional samples of similar DNA quality and con-
centration were used to ﬁll a complete plate for geno-
typing (382 samples and two controls).
Fearful aﬀect facial recognition task
This comprised a 5-min, event-related task. Ten dif-
ferent facial identities (six female, four male ; www.
paulekman.com) depicting 150% intensity of a fearful
expression were presented in a pseudo-random order
interspersed with a ﬁxation cross, and the same facial
identities showing a neutral expression acted as a
control condition. The 150% level of intensity was
chosen to minimize ambiguity and uncertainty about
the nature of the stimuli. In addition as noted by
Phillips et al. (1997) images showing facial aﬀect at
150% are recognized faster than images showing 75%
and 100% of facial aﬀect regardless of the actual
nature of the aﬀect (Calder et al., 1997).
Each image was displayed for 2 s and the inter-
stimulus interval followed a Poisson distribution and
was varied between 3 s and 9 s (mean interval 5 s). In
all 60 images were displayed; the ﬁxation cross, faces
with neutral expression, and faces expressing fear
were each displayed 20 times. Participants were in-
structed to respond to fearful faces and faces with
neutral expression by pressing the right and left but-
ton respectively on a MRI-compatible response box.
No response was required when subjects viewed the
ﬁxation cross. Response time and accuracy data were
collected.
Image acquisition
Gradient echo planar MR images were acquired using
a 1.5 T GE Sigma MR system (General Electric,
Milwaukee, WI, USA) ﬁtted with 40 mT/m high-
speed gradients. Foam padding and a forehead strap
was used to limit head motion, and a quadrature
birdcage head coil was used for radio frequency (RF)
transmission and reception. In each of the 16 non-
contiguous planes parallel to the inter-commissural
(AC–PC) plane, T2*-weighted MR images depicting
blood-oxygenation level-dependent (BOLD) contrast
were acquired (TR=2000 ms, TE=40 ms, ﬂip angle=
Table 1. Demographic information and task performance
Met/Met
(n=20)
Met/Val
(n=32)
Val/Val
(n=22) Statistic
Age (yr) 34.6 (15.6) 35.7 (12.5) 33.9 (13.7) F2,71=0.12, p=0.88
Gender (M:F) 11 :9 18 :14 11 :11 x (2)
2 =0.22, p=0.90
Educational level 3.4 (0.9) 3.7 (0.9) 3.5 (1.0) F2,71=0.94, p=0.39
WAIS-R IQ 115.1 (20.1) 119.0 (14.7) 117.6 (20.3) F2,61=0.24, p=0.79
Correctly identiﬁed
faces (%)
96.0 (6.3) 97.1 (5.0) 97.3 (4.5) F2,71=0.37, p=0.69
Response time (ms) 1050 (166) 1013 (165) 1116 (258) F2,71=1.8, p=0.18
WAIS-R, Wechsler Adult Intelligence Scale – Revised.
Data are expressed as mean (S.D.).
For WAIS-R IQ: n=16 for Met/Met, n=28 for Met/Val, n=20 for Val/Val.
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70x, slice thickness=7 mm, slice skip=0.7 mm, matrix
size 64r64, voxel dimensions 3.75r3.75r7.7 mm). In
the facial aﬀect discrimination task 150 images were
acquired. During the same session, a high-resolution
T1 weighted structural image was acquired in the
axial plane (inversion recovery prepared, spoiled
gradient-echo sequence ; TR=18 ms, TE=5.1 ms, TI=
450 ms, ﬂip angle=20x, slice thickness=1.5 mm,
matrix size 256r192, FOV 240r180 mm, voxel di-
mensions 0.9375r0.9375r1.5 mm, NEX=1) for sub-
sequent Talairach mapping (Talairach and Tourneaux,
1988).
Image analysis
Statistical analysis of the fMRI data was performed
using SPM5 (Statistical Parametric Mapping, Well-
come Department of Imaging Neuroscience, London).
Preprocessing
Images were realigned to correct for movement and
normalized into MNI space using the participant’s
structural MRI image. The transformed dataset for
each subject was smoothed with an isotropic Gaussian
ﬁlter (full width half maximum=8 mm) to compen-
sate for normal variation in structural and functional
anatomy across subjects.
First level analysis
Vectors of onset representing the correctly identiﬁed
fearful faces and correctly identiﬁed neutral faces were
convolved with the haemodynamic response function,
global signal changes were removed and a high pass
ﬁlter (128 s) was applied to remove low-frequency
artefacts for each subject. In the design matrix we also
modelled the ﬁxation cross, incorrect responses, and
subject button response, although contrasts comparing
these conditions were not used in the second level
analysis. An explicit mask was used to ensure only
voxels within the brain were included in the analysis.
Six movement parameters were entered as nuisance
covariates and contrast images of brain activations
associated with correct recognition of fearful faces
compared to neutral faces were produced for each
participant.
Second level analysis
For the second level, random eﬀects analysis, contrast
images produced at the ﬁrst level were used. First, a
one-sample t test was utilized combining all groups to
investigate the main eﬀect of task (correctly identiﬁed
fearful faces>correctly identiﬁed neutral faces). As
the eﬀect size of genotype and genotype x gender in-
teractions on brain activation is likely to be small and
would not survive whole-brain correction for multiple
comparisons, we used a region-of-interest (ROI) analy-
sis, an approach adopted by other investigators
(Drabant et al., 2006; Hariri et al., 2005 ; Smolka et al.,
2005). As we were particularly interested in focusing
on brain clusters modulated by gender we restricted
our analysis to these speciﬁc areas.
These clusters were identiﬁed using an analysis of
variance (ANOVA) model in SPM with gender as a
factor. MarsBaR (Brett et al., 2002) was then used to
extract measures of brain activation (weighted par-
ameter estimates) from each subject at these particular
clusters. Weighted parameter estimates were analysed
using an ANOVA model within SPSS version 15.0
(SPSS Inc., Chicago, IL, USA) with gender and COMT
genotype as factors. Partial eta squared (g2) was used
as an estimate of eﬀect size.
For the group task-related activation map a p<0.05
voxel-level, family-wise error (FWE) corrected thresh-
old was used, and when investigating gender dif-
ferences a p<0.001 voxel-level uncorrected threshold
was employed based on the recommendations of
Thirion et al. (2007) with a minimum cluster size of 25
voxels. In addition to the whole-brain analysis above
we also examined activation in the amygdala which
is consistently engaged by fearful stimuli as shown
in fMRI meta-analyses (Murphy et al., 2003 ; Phan
et al., 2002). The Wake Forest University Pickatlas
was used to deﬁne the amygdala small-volume cor-
rection (http://www.fmri.wfubmc.edu/download.
htm) (Maldjian et al., 2003) and activationswere thresh-
olded at the p<0.05 FWE-corrected level.
Supplementary MarsBaR analysis to investigate
confounding eﬀect of age and menstrual status
We undertook two additional analyses on activation
levels of gender-modulated regions extracted with
MarsBaR. As our sample included a relatively large
age range, the MarsBaR analysis was repeated in-
cluding age as a nuisance covariate. Oestrogen was not
directly measured in this study. As a proxy marker we
divided the female sample into two groups, one aged
f35 yr and the other o55 yr, the latter group as-
sumed to be post-menopausal. We then compared the
brain activation levels in the MarsBaR analysis be-
tween the two groups using an independent-sample
t test.
For all analyses, MNI coordinates produced by SPM
were converted to Talairach coordinates (Duncan et al.,
2000) and corresponding brain regions were identiﬁed
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with the Talairach Daemon Client (Lancaster et al.,
2000).
Potential diﬀerences by genotype in age, gender,
educational level and IQ were assessed using
univariate ANOVAs or x2 tests as appropriate within
SPSS 15.0. Mean accuracy and mean response time
to fearful faces were analysed using ANOVAs with
genotype and gender as factors.
Results
There was no signiﬁcant eﬀect of genotype on age,
gender, educational level, or IQ (see Table 1). Allele
frequencies did not violate the Hardy–Weinberg
principle among males (x2=0.4, d.f.=1, p=0.53),
females (x2=1.02, d.f.=1, p=0.31), or in the entire
sample (x2=1.34, d.f.=1, p=0.25). We found no sig-
niﬁcant eﬀect of COMT allele, gender, or COMT
allelergender interaction on accuracy or response
time in the task.
Eﬀect of task
With all genotype groups combined, the fearful aﬀect
recognition task (fearful faces compared to neutral
faces) activated regions in the left occipital gyrus
[Brodmann area (BA) 18, Talairach coordinates=x32,
x88, x2 ; Z score=7.15, cluster size=1172 voxels],
right lingual gyrus (BA 18, coordinates=14,x82,x4;
Z=6.50, cluster size=262), right fusiform gyrus (BA
37, coordinates=40,x57,x14 ; Z=6.30, cluster size=
455) and left post-central gyrus (BA 40, coordinates=
x51, x32, 51 ; Z=6.12, cluster size=1183). For the
small-volume-correction analysis of the amygdala, we
observed bilateral activation of this region (left amyg-
dala coordinates=x22, x4, x16 ; Z=4.26 cluster
size=127; right amygdala coordinates=20,x4,x20;
Z=3.84, cluster size=58).
Eﬀect of gender on task activations
An eﬀect of gender was observed on task-related
activations in the left amygdala (Talairach co-
ordinates=x36, x3, x22 ; Z=3.72, cluster size=58
voxels), in the region of the right temporal pole on the
superior temporal gyrus (BA 38, coordinates=50, 16,
x26 ; Z=3.46, cluster size=41), in the left superior
occipital gyrus (BA 19, coordinates=x42, x80, 35;
Z=3.86, cluster size=47) and the right precentral gy-
rus (BA 4, coordinates=51, x10, 39 ; Z=3.58, cluster
size=76). Females showed increased activation in the
left amygdala, right temporal polar region and left
superior occipital gyrus, while males demonstrated
greater activations in the right precentral gyrus. The
location of the clusters, and weighted parameter esti-
mates for the left amygdala and right temporal pole
are shown in Figure 1.
Eﬀect of genotype within clusters modulated
by gender
Within the left amygdala and right temporal polar re-
gion females demonstrated activations during the
task, which were greater for female Val/Val than fe-
male Met/Met carriers. In contrast, males showed de-
activation in both these regions with Met/Met carriers
showing greater deactivation than Val/Val carriers.
The left superior occipital gyrus revealed a diﬀerent
pattern with females showing little change from base-
line and male Met/Met carriers showing greater de-
activation than male Val/Val carriers. In the right
precentral gyrus deactivation was observed in females
while males showed little change from baseline. For
the left amygdala, brain activation values extracted
using MarsBaR, revealed a main eﬀect of gender
(F1,68=20.2, p<0.001, g2=0.23), main eﬀect of geno-
type (F2,68=4.6, p=0.013, g2=0.12) but no genotyper
gender interaction (F2,68=0.64, p=0.53, g2=0.02). For
the right temporal pole, there was a main eﬀect of
gender (F1,68=18.4, p<.001, g2=0.21) a trend for a
main eﬀect of genotype (F2,68=2.8, p=0.069, g2=0.08)
and a genotypergender interaction (F2,68=3.8, p=
0.028, g2=0.10). For the left superior occipital gyrus
there was a main eﬀect of gender (F1,68=15.1, p<0.001,
g2=0.18), no main eﬀect of genotype (F2,68=0.036,
p=0.97, g2<0.01) and no genotypergender interac-
tion (F2,68=1.27, p=0.29, g2=0.04), and for the right
precentral gyrus there was a main eﬀect of gender
(F1,68=14.0, p<0.001, g2=0.17) no main eﬀect of
genotype (F2,68=1.32, p=0.27, g2=0.04) and no geno-
typergender interaction (F2,68=1.80, p=0.17, g2=
0.05).
The results did not change when age was used as
a nuisance covariate and there was no diﬀerence
in brain activation within these regions between
menopausal (f35 yr) and post-menopausal (o55 yr)
females (p>0.2 for all clusters).
In summary, during this fearful aﬀect recognition
paradigm, the level of the BOLD signal in regions
showing a gender eﬀect was further modulated
by COMT genotype in the left amygdala while a
genotypergender interaction was observed in the
right temporal polar region.
In terms of the cognitive paradigm our study most
closely resembles that of Drabant et al. (2006). We
therefore explored the eﬀect of gender and genotype
on the hippocampal and ventrolateral prefrontal
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cortical ROIs used by Drabant et al. based on the Wake
Forest University Pickatlas. Small-volume-correction
analysis showed no signiﬁcant eﬀect of genotype or
genotypergender interaction on brain activation in
these regions (all p>0.1 corrected for ROI volume).
Discussion
During fearful facial aﬀect recognition, diﬀerences in
BOLD signal intensity, depending on gender were
observed in left amygdala, right temporal polar re-
gion, left superior occipital gyrus and right precentral
gyrus. Within these regions, an eﬀect of genotype was
seen for the left amygdala and a genderrgenotype
interaction was observed in the right temporal polar
area.
Main eﬀect of gender
We found that females showed increased task-related
activation compared to males in the left amygdala
whilst males appeared to inhibit neural response in
this region.
In their meta-analysis of neuroimaging studies of
emotional processing Wager et al. (2003) noted that
amygdala involvement was generally more common
on the left with gender diﬀerences in the distribution
of peak activations. In females peak activations were
more anterior and dorsal compared to males, often
including the temporal pole and parahippocampal
gyrus.
Engagement of the amygdala is reliably seen in
fMRI studies of emotional facial aﬀect recognition
particularly in response to stimuli with negative
aﬀective content (Adolphs, 1999 ; Murphy et al., 2003).
Amygdala activation is perhaps most consistently ob-
served in response to passive or implicit viewing of
fearful facial expressions (Phan et al., 2002). The pre-
dominance of left-lateralized amygdala activation
during fearful facial aﬀect recognition is thought to
reﬂect the more rapid habituation of the right amyg-
dala to repeated presentations of fearful stimuli
(Wright et al., 2001). Amygdala responses are reduced
when explicit labelling of the emotional expression is
required (Critchley et al., 2000 ; Hariri et al., 2000) due
to prefrontal inhibition.
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Figure 1. (a) Main eﬀect of gender on brain activations during the fearful facial aﬀect recognition task showing the four
most signiﬁcant clusters (images thresholded at p<0.005 uncorrected). (b) Brain activations for the left amygdala and right
temporal pole divided by gender and genotype. L Amyg, Left amygdala ; RPT, right temporal pole, LGOs, left superior
occipital gyrus, RGPrC, right precentral gyrus.
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In the present study, deactivation of the left amyg-
dala and the right temporal pole was observed in
male but not in female participants. In addition to, and
in agreement with our ﬁndings Koch et al. (2007) re-
cently reported activation in the left amygdala of fe-
male participants, during a fMRI task that involved
cognitive control of negative emotions, while males
were successful in inhibiting amygdala response.
Therefore our ﬁndings suggest that prefrontal inhibi-
tory control of amygdala activation during negative
emotional processing is more eﬀective in males than in
females.
Males also showed relative deactivation within the
left superior occipital gyrus (BA 19), which was absent
in females. BA 19 is part of the extrastriate visual cor-
tex and primarily involved in early perceptual pro-
cessing. Our results support current views that the
amygdala modulates responses to emotional stimuli in
visual cortices (Adolphs, 2002 ; Stein et al., 2007) ; and
suggest that inhibitory feedback to the visual cortex by
the amygdala is greater in males than females.
Engagement of the somatosensory cortex within the
precentral gyri has often been observed in tasks in-
volving assessment of facial aﬀect and are interpreted
as evidence of internal representation of somatic ex-
periences associated with the observed emotional ex-
pressions (Adolphs, 2002). This study suggests that
this emotional mimicry is perhaps minimal in males
whereas in females there may be increased inhibition
in this region.
COMT Val158Met polymorphism and gender
Our results suggest that Val homozygocity ampliﬁes
the magnitude of the BOLD signal in the amygdala
and associated temporal polar regions in response
to fearful faces. In the extrastriate visual and somato-
sensory cortices there was no signiﬁcant eﬀect of
genotype or genderrgenotype interaction.
Our results diﬀer signiﬁcantly from those of
Drabant et al. (2006) who also examined the eﬀect of
the Val158Met polymorphism on facial aﬀect recog-
nition in healthy individuals. In their sample of 24 Met
and 20 Val homozygotes and 57 heterozygotes, they
observed greater right hippocampal and right ventro-
lateral PFC (BA 45) activity in Met compared to Val
homozygotes, but did not investigate the eﬀect of
gender. Similarly, an association between the number
of Met alleles and increased activation in the amyg-
dala/hippocampus complex in response to unpleasant
pictures has also been reported (Smolka et al., 2005). It
is possible that we were unable to detect a modulatory
eﬀect of COMT genotype within these brain regions
because our sample was smaller, or because we did
not control for other single nucleotide polymorphisms
such as 5-HTTLPR genotype status which may modu-
late aﬀective processing.
The paradigms in the above studies were based on
passive viewing of negative facial expressions or
aversive images while the one used in the present
study required explicit labelling of facial expressions
as neutral or fearful. Functional imaging studies have
corroborated the notion that limbic responses are
reduced when explicit labelling of an emotional
expression is required due to prefrontal inhibition
(Critchley et al., 2000; Hariri et al., 2000) and as
already discussed this mechanism appears more ef-
fective in males regardless of COMT genotype.
Our results may be best explained by the model for
the eﬀect of the COMT Val158Met polymorphism on
cognitive processing proposed by Bilder et al. (2004)
based on the role of tonic and phasic DA release
(Grace, 1991). According to this model, dynamic DA
regulation within limbic regions results from two
processes. First, high-amplitude transient, ‘phasic’
DA release occurs in response to relevant environ-
mental stimuli and is mediated by dopaminergic
neurone burst ﬁring. Second, constant, low-level,
‘ tonic’ DA concentration is regulated by baseline
dopaminergic neurone ﬁring and cortical aﬀerents.
Tonic DA levels regulate the amplitude of the phasic
DA release by stimulating highly sensitiveDA terminal
autoreceptors. Phasic DA release acts at post-synaptic
targets and is thought to be regulated by dopamine
transporter (DAT) activity (Floresco et al., 2003 ; Grace,
1991, 1993 ; Moore et al., 1999) ; and not by COMT,
given that it is not present in DA terminals (Gogos
et al., 1998). Although COMT is expressed through-
out the brain, Hong et al. (1998) have found the
lowest expression evident in the amygdala whilst
Revay et al. (1996) have provided evidence that
amygdala DA catabolism is mainly mediated by the
DAT. Within this framework, higher tonic DA con-
centration in the amygdala, putatively associated with
the low-activity COMT Met158 allele, would reduce
the amplitude of phasic DA release while the
opposite would be the case for the COMT Val158
allele. At the same time, the presence of the COMT
Met158 allele should be associated, at least in theory,
with more eﬃcient PFC function, and therefore
improved inhibitory regulation in COMT Met allele
carriers.
In line with the above model, female COMT Val158
homozygotes had the largest amygdala activation,
which may be interpreted as indicative of greater
‘phasic ’ response to fearful vs. neutral faces. Female
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COMT Met158 homozygotes showed smaller amyg-
dala response which may reﬂect the inhibitory eﬀects
of higher tonic DA levels on phasic release and
perhaps more eﬃcient PFC regulation. The pattern
seen in males is also suggestive of a more eﬀective
deactivation of the amygdala associated with the
COMTMet158 allele. The proposed inhibitory eﬀect of
oestrogen on COMT activity was modest and only
reached signiﬁcance for the right temporal polar re-
gion.
We did not examine potential genderrgenotype
interactions on regional brain volumes but this is un-
likely to have inﬂuenced our results since Zinkstok
et al. (2006) found no such interaction in a sample of
154 healthy controls. We also did not control for
menstrual cycle in female participants which may af-
fect central DA neurotransmission. In healthy females
positron emission tomography (PET) studies suggest
reduced DA receptor density in the striatum during
the luteal phase while prememopausal females with
Parkinson’s disease show symptomatic worsening
also during the luteal phase which coincides with
lower oestrogen levels, (Munro et al., 2006 ; Quinn and
Marsden, 1986; Wong et al., 1988). However, no dif-
ferences in regional brain activations were found
when we compared females aged f35 yr to females
o55 yr, the latter presumed to be post-menopausal.
Finally, other genetic (or even non-genetic) inﬂuences
may impact on task-induced limbic activation during
fearful facial aﬀect recognition. Two obvious examples
are the DAT gene, which is largely responsible for
DA catabolism in the amygdala, and the regulatory
region (5-HTTLPR) of the serotonin transporter gene,
which is known to interact with the COMT Val158Met
polymorphism (Smolka et al., 2007) during aﬀective
information processing. Although representative of the
adult population, the age range in our sample was
relatively large but the results remained unchanged
when we included age as a nuisance covariate.
In summary this study provides evidence for an
eﬀect of the COMT Val158Met polymorphism on task-
induced limbic activation during fearful aﬀect rec-
ognition with the Val allele being associated with
ampliﬁed limbic response particularly in females.
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